ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded Eligibility for Early Stage Breast Cancer Patients in a Large Integrated Health System

Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16559-0. Online ahead of print.
No abstract available